RECORD // Company

Avalyn Pharma Inc.

Formerly: Genoa Pharmaceuticals, Inc.

Built 2026-11-22T00:39:06Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (3)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Avalyn Pharma Inc. · Ct business · same registered legal name as 'Avalyn Pharma Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Avalyn Pharma Inc. · Ctgov · same registered legal name as 'Avalyn Pharma Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • AVALYN PHARMA INC. · East licences · same registered legal name as 'Avalyn Pharma Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare

8 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001193125-26-457071

ItemValuePeriodFormFiledAccessionReport
Net income (loss)$-29,655,0003 months ended 2026-09-3010-Q2026-11-120001193125-26-4570712026-11-22 00:39 UTCReport an error
Interest expense$277,0003 months ended 2026-09-3010-Q2026-11-120001193125-26-4570712026-11-22 00:39 UTCReport an error
Cash and cash equivalents$145,424,000at 2026-09-3010-Q2026-11-120001193125-26-4570712026-11-22 00:39 UTCReport an error
Debt due in the next 12 months$0at 2026-09-3010-Q2026-11-120001193125-26-4570712026-11-22 00:39 UTCReport an error
Debt due in year 2$0at 2026-09-3010-Q2026-11-120001193125-26-4570712026-11-22 00:39 UTCReport an error
Debt due in year 3$6,000,000at 2026-09-3010-Q2026-11-120001193125-26-4570712026-11-22 00:39 UTCReport an error
Debt due in year 4$6,000,000at 2026-09-3010-Q2026-11-120001193125-26-4570712026-11-22 00:39 UTCReport an error
Debt due in year 5$3,000,000at 2026-09-3010-Q2026-11-120001193125-26-4570712026-11-22 00:39 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Revenue.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001540171
Ticker
AVLN
EIN
452463191
CUSIP
05348Y105
Record ID
sx:sec:0001540171

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

23 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-19SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-19SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
State of incorporationDE2026-11-19SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
Fiscal year end (MMDD)12312026-11-19SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
Business address105 W FIRST ST., BOSTON, MA, 021272026-11-19SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
ExchangesNasdaq2026-11-19SEC EDGAR company profile2026-11-22 00:39 UTCReport an error
Form D total offering amount (D filed 2023-10-10)$189,182,6222023-10-10D2026-11-22 00:39 UTCReport an error
Form D total amount sold (D filed 2023-10-10)$189,182,6222023-10-10D2026-11-22 00:39 UTCReport an error
Form D industry groupBiotechnology2023-10-10D2026-11-22 00:39 UTCReport an error
Form D revenue rangeDecline to Disclose2023-10-10D2026-11-22 00:39 UTCReport an error
Form D date of first sale2023-09-222023-10-10D2026-11-22 00:39 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-12)On November 12, 2026, Avalyn Pharma Inc. (the “Company”) announced its financial results for the quarter ended September 30, 2026. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information included under Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto), is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act…2026-11-12SEC EDGAR 8-K 0001193125-26-457053 (text as filed, excerpt)2026-11-22 00:39 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-12)On August 12, 2026, Avalyn Pharma Inc. (the “Company”) announced its financial results for the quarter ended June 30, 2026. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information included under Item 2.02 of this Current Report on Form 8-K (including Exhibit 99.1 attached hereto), is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as…2026-08-12SEC EDGAR 8-K 0001193125-26-345807 (text as filed, excerpt)2026-11-22 00:39 UTCReport an error
Largest institutional holder #1 (13F as filed): FMR LLC$192,096,7262026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #2 (13F as filed): NOVO HOLDINGS A/S$127,837,8742026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #3 (13F as filed): SR One Capital Management, LP$108,920,7252026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #4 (13F as filed): PERCEPTIVE ADVISORS LLC$88,070,7442026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #5 (13F as filed): MONTANOVA CAPITAL, LLC$82,402,3482026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #6 (13F as filed): NVP ASSOCIATES, LLC$74,675,8602026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #7 (13F as filed): WELLINGTON MANAGEMENT GROUP LLP$72,489,3792026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #8 (13F as filed): Catalio Capital Management, LP$55,168,3242026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #9 (13F as filed): EVENTIDE ASSET MANAGEMENT, LLC$45,280,9992026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error
Largest institutional holder #10 (13F as filed): Bellevue Group AG$44,442,0002026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-22 00:39 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.